ALPHARMA PHARMACEUTICALS: 'ALO-01 (Morphine Sulfate Extended-Release With Sequestered Naltrexone Hydrochloride) Capsules' 14 November 2008, (B1)

Clinical Trials.gov: "A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence", clinicaltrials.gov , 21 September 2009 (2009-09-21), Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 00981617/2009_09_21 [retrieved on 2016-06-21] (B1)

DATABASE REGISTRY [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 21 June 2005 (2005-06-21), retrieved from STN accession no. 852626-89-2 Database accession no. 852626-89-2 (B1)

DEAN R L ET AL: "Novel orally active opioid antagonists reduce alcohol drinking in rats", ALCOHOLISM CLINICAL AND EXPERIMENTAL RESEARCH, vol. 32, no. 6, Suppl. 1, June 2008 (2008-06), page 83A, & JOINT SCIENTIFIC MEETING OF THE RESEARCH-SOCIETY-ON-ALCOHOLISM AND THE INTERNATIONAL-SOCIETY-FOR-BIO; WASHINGTON, DC, USA; JUNE 27 -JULY 02, 2008 ISSN: 0145-6008 (B1)

LEO BELETSKY ET AL: "Physicians' Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities", JOURNAL OF URBAN HEALTH ; BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 84, no. 1, 5 December 2006 (2006-12-05), pages 126-136, XP019469941, ISSN: 1468-2869 (B1)

SHANE DARKE ET AL: "Heroin overdose: Research and evidence-based intervention", JOURNAL OF URBAN HEALTH ; BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 80, no. 2, 1 June 2003 (2003-06-01), pages 189-200, XP019415317, ISSN: 1468-2869, DOI: 10.1093/JURBAN/JTG022 (B1)

WO-A1-2010/107457 (B1)

TURNCLIFF R ET AL: "PREDICTIVE METABOLISM AND BIOAVAILABILITY OF RDC-0313, A NOVEL OPIOID RECEPTOR ANTAGONIS", CLINICAL PHARMACOLOGY AND THERAPEUTICS, NATURE PUBLISHING GROUP, US, vol. 85, no. Suppl. 1, 1 February 2009 (2009-02-01), page S59, XP008152832, ISSN: 0009-9236 (B1)

US-A1- 2009 209 569 (B1)

US-B2- 7 262 298 (B1)

WENTLAND M P ET AL: "Syntheses of novel high affinity ligands for opioid receptors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 19, no. 8, 15 April 2009 (2009-04-15) , pages 2289-2294, XP026079458, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2009.02.078 [retrieved on 2009-02-25] (B1)

WENTLAND M P ET AL: "Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 15, no. 8, 15 April 2005 (2005-04-15) , pages 2107-2110, XP027801773, ISSN: 0960-894X [retrieved on 2005-04-15] (B1)

TODTENKOPF M S ET AL: "In vitro and in vivo characterization of novel opioid antagonists", ALCOHOLISM CLINICAL AND EXPERIMENTAL RESEARCH, vol. 32, no. 6, Suppl. 1, June 2008 (2008-06), page 83A, & JOINT SCIENTIFIC MEETING OF THE RESEARCH-SOCIETY-ON-ALCOHOLISM AND THE INTERNATIONAL-SOCIETY-FOR-BIO; WASHINGTON, DC, USA; JUNE 27 -JULY 02, 2008 ISSN: 0145-6008 (B1)